Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet 371620002
SNOMED CT code
SNOMED code | 371620002 |
---|---|
name | Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet |
status | active |
date introduced | 2002-07-31 |
fully specified name(s) | Product containing precisely methenamine mandelate 300 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
synonyms | Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet |
attributes - group0 | |
Plays role | Laxative therapeutic role 773905006 |
Plays role | Antibacterial therapeutic role 787994008 |
Has manufactured dose form | Oral tablet 421026006 |
Has unit of presentation | Tablet 732936001 |
attributes - group2 | |
Has precise active ingredient | Methenamine mandelate 68293009 |
Has presentation strength numerator unit | mg 258684004 |
Has presentation strength denominator unit | Tablet 732936001 |
Has BoSS | Methenamine mandelate 68293009 |
attributes - group1 | |
Has precise active ingredient | Monobasic sodium phosphate 116124008 |
Has presentation strength numerator unit | mg 258684004 |
Has presentation strength denominator unit | Tablet 732936001 |
Has BoSS | Monobasic sodium phosphate 116124008 |
parents | Methenamine and monobasic sodium phosphate only product in oral dose form 779837000 |
hierarchies | a selection of possible paths SNOMED CT Concept 138875005Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Product manufactured as oral dose form 440131009 Methenamine-containing product in oral dose form 772600009 Methenamine- and monobasic sodium phosphate-containing product in oral dose form 772601008 Methenamine and monobasic sodium phosphate only product in oral dose form 779837000 Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet 371620002 |
ancestors | sorted most to least specific
|
cpt crosswalks |
Thank you for choosing Find-A-Code, please Sign In to remove ads.